FR0010331421 - Common Stock
We assign a technical rating of 0 out of 10 to IPH. IPH scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
2.47
Although the technical rating is bad, IPH does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period.
EPA:IPH (5/16/2022, 5:27:41 PM)+0.06 (+2.31%)
GICS Sector | Health Care | ||
GICS Industry | Biotechnology |
Today | 2.31% | 1 Week | 13.45% |
2 Weeks | 5.75% | 1 Month | -1.25% |
3 Month | -11.05% | 6 Month | -35.33% |
ATR(14) | 0.14 | ATR(20)% | 4.3% |
ATR Inc | -5.21% | Range Today | 0.07 |
ST Trend | LT Trend | ||
SMA(5) | SMA(10) | ||
SMA(20) | SMA(50) | ||
SMA(100) | SMA(200) |
CRS | 23.32 | Mansfield | -1.43 |
10 Day High | 2.84 | 10 Day Low | 2.49 |
20 Day High | 2.96 | 20 Day Low | 2.49 |
52 Week High | 8.28 | 52 Week Low | 2.44 |
CS1 End | 2.49 | CR1 Start | 2.85 |
DER(3) | 2.31% | DER(5) | 1.4% |
Volume | 3.48K | Volume Incr | -26.8% |
Vol(5) | 122.59K | Vol(50) | 205.55K |
Find stocks with similar TA and Setup ratings on the EuroNext
Find the competitors with the best technical ratings on the EuroNext
Find the competitors with the best technical and setup ratings on the EuroNext